IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb
Medical Services Advisory Committee
Record ID 32015000450
English
Authors' objectives:
Blepharospasm is a chronic progressive disorder, defined as involuntary, sporadic or permanent eyelid closure resulting in significant visual disability.
Cervical dystonia (spasmodic torticollis) covers a spectrum of involuntary movements with abnormal posture of the head and shoulder/neck region.
Post-stroke spasticity of the upper limb imposes a considerable humanistic burden. It is not only painful, but is often associated with functional impairment in personal hygiene and dressing, necessitating the help of a family member or professional caregiver.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1379-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Stroke
- Upper Extremity
- Botulinum Toxins, Type A
- Blepharospasm
- Dystonia
- Neuromuscular Agents
- Neurotoxins
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
<p>Medical Services Advisory Committee (MSAC)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.